FDA Approves Ryzneuta (efbemalenograstim alfa) for Chemotherapy-Induced Neutropenia

November 22, 2023, New Jersey– Evive Biotech (Evive), a global biopharmaceutical company devoted to developing novel biologic therapies and a subsidiary of Yifan Pharmaceutical Co. Ltd., and Acrotech Biopharma (Acrotech), a New Jersey-based...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news